Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Kaleido Biosciences Inc

(NASDAQ: KLDO)
Add to Portfolio
+0.25 (+4.55%)
as of Jan 22, 2020

Profile
Ticker Symbol KLDO
Exchange NASDAQ
Contact Information

,
P:
CEO/President
Earnings at a Glance
Price Earnings Ratio N/A
EPS Growth 28.99
Most Recent Earnings ($) -0.74
Annual EPS ($) N/A
Business Summary
Kaleido Biosciences Inc. is a clinical-stage healthcare company. It focuses on leveraging the potential of the microbiome organ to treat disease and improve human health. The Company's product candidates are Microbiome Metabolic Therapies(TM) which are designed to modulate the metabolic output and profile of the microbiome by driving the function and distribution of the organ's existing microbes. Kaleido Biosciences Inc. is based in Lexington Massachusetts.
Industry/Sector Medical - Biomedical
Indices Russell 2000